FR2855969B1 - Stimulation de l'activite d'une isoforme de lysyl oxydase pour lutter contre certaines pathologies dues a une elastogenese incomplete, absente ou desorganisee - Google Patents

Stimulation de l'activite d'une isoforme de lysyl oxydase pour lutter contre certaines pathologies dues a une elastogenese incomplete, absente ou desorganisee

Info

Publication number
FR2855969B1
FR2855969B1 FR0307178A FR0307178A FR2855969B1 FR 2855969 B1 FR2855969 B1 FR 2855969B1 FR 0307178 A FR0307178 A FR 0307178A FR 0307178 A FR0307178 A FR 0307178A FR 2855969 B1 FR2855969 B1 FR 2855969B1
Authority
FR
France
Prior art keywords
elastogenesis
disorganized
incomplete
stimulation
absent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0307178A
Other languages
English (en)
Other versions
FR2855969A1 (fr
Inventor
Charbel Bouez
Valerie Cenizo
Pascal Sommer
Baudoux Odile Damour
Claudine Gleyzal
Valerie Andre
Corinne Reymermier
Isabelle Orly
Eric Perrier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
BASF Beauty Care Solutions France SAS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Coletica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Coletica SA filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR0307178A priority Critical patent/FR2855969B1/fr
Priority to US10/852,575 priority patent/US20040258676A1/en
Priority to DE102004028300A priority patent/DE102004028300B4/de
Priority to KR1020040043111A priority patent/KR100787553B1/ko
Publication of FR2855969A1 publication Critical patent/FR2855969A1/fr
Priority to KR1020070070286A priority patent/KR100844914B1/ko
Application granted granted Critical
Publication of FR2855969B1 publication Critical patent/FR2855969B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8998—Hordeum (barley)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9064—Amomum, e.g. round cardamom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y104/00—Oxidoreductases acting on the CH-NH2 group of donors (1.4)
    • C12Y104/03—Oxidoreductases acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
    • C12Y104/03013—Protein-lysine 6-oxidase (1.4.3.13), i.e. lysyl-oxidase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06—Lipsticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0307178A 2003-06-13 2003-06-13 Stimulation de l'activite d'une isoforme de lysyl oxydase pour lutter contre certaines pathologies dues a une elastogenese incomplete, absente ou desorganisee Expired - Lifetime FR2855969B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0307178A FR2855969B1 (fr) 2003-06-13 2003-06-13 Stimulation de l'activite d'une isoforme de lysyl oxydase pour lutter contre certaines pathologies dues a une elastogenese incomplete, absente ou desorganisee
US10/852,575 US20040258676A1 (en) 2003-06-13 2004-05-24 Stimulation of the activity of an isoform of lysyl oxidase for combating against some pathologies due to an incomplete, absent or disorganized elastogenesis
DE102004028300A DE102004028300B4 (de) 2003-06-13 2004-06-11 Stimulierung der Aktivität eines Isoform des Lysyloxidase zum Bekämpfen von einigen Pathologien, die durch eine unvollständige, fehlende oder desorganisierte Elastogenese verursacht sind
KR1020040043111A KR100787553B1 (ko) 2003-06-13 2004-06-11 탄력섬유형성의 불완전, 결여 혹은 해체로 인한 질병을 제어하는 라이실 옥시다제의 동종효소의 활성 촉진
KR1020070070286A KR100844914B1 (ko) 2003-06-13 2007-07-12 탄력섬유형성의 불완전, 결여 혹은 해체로 인한 질병을제어하는 라이실 옥시다제의 동종효소의 활성 촉진

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0307178A FR2855969B1 (fr) 2003-06-13 2003-06-13 Stimulation de l'activite d'une isoforme de lysyl oxydase pour lutter contre certaines pathologies dues a une elastogenese incomplete, absente ou desorganisee

Publications (2)

Publication Number Publication Date
FR2855969A1 FR2855969A1 (fr) 2004-12-17
FR2855969B1 true FR2855969B1 (fr) 2012-11-30

Family

ID=33484438

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0307178A Expired - Lifetime FR2855969B1 (fr) 2003-06-13 2003-06-13 Stimulation de l'activite d'une isoforme de lysyl oxydase pour lutter contre certaines pathologies dues a une elastogenese incomplete, absente ou desorganisee

Country Status (4)

Country Link
US (1) US20040258676A1 (fr)
KR (2) KR100787553B1 (fr)
DE (1) DE102004028300B4 (fr)
FR (1) FR2855969B1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114410A1 (en) 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
JP2007526247A (ja) 2004-01-23 2007-09-13 マサチューセッツ・アイ・アンド・イア・インファーマリー リジルオキシダーゼ様１（ｌｏｘｌ１）および弾性繊維形成
FR2892635B1 (fr) * 2005-10-28 2012-11-09 Engelhard Lyon Substance pour restaurer une co-expression et une interaction normales entre les proteines lox et nrage
ES2700141T3 (es) 2007-08-02 2019-02-14 Gilead Biologics Inc Anticuerpos inhibidores LOXL2 y usos de los mismos
US9107935B2 (en) 2009-01-06 2015-08-18 Gilead Biologics, Inc. Chemotherapeutic methods and compositions
RU2012110585A (ru) 2009-08-21 2013-09-27 Джилид Байолоджикс, Инк. Каталичические домены лизилоксидазы и loxl2
FR2954702B1 (fr) 2009-12-31 2013-07-05 Basf Beauty Care Solutions F Agent stimulant l'expression de loxl
US8680246B2 (en) 2010-02-04 2014-03-25 Gilead Biologics, Inc. Antibodies that bind to lysyl oxidase-like 2 (LOXL2)
HUE060291T2 (hu) 2011-09-30 2023-02-28 Allergan Pharmaceuticals Int Ltd Rugalmas rost in vivo szintézise
US9688741B2 (en) 2012-10-23 2017-06-27 Elastagen Pty Ltd Elastic hydrogel
ES2860023T3 (es) 2012-12-10 2021-10-04 Allergan Pharmaceuticals Int Ltd Fabricación de constructos elásticos tridimensionales escalables
EP4316537A3 (fr) 2013-08-13 2024-04-10 Allergan Pharmaceuticals International Limited Régénération de tissu endommagé
FR3010313A1 (fr) 2013-09-09 2015-03-13 Natura Cosmeticos Sa Composition comprenant un extrait de guacatonga et un extrait d'aroeira, son utilisation et methode pour empecher et/ou traiter les signes causes par le vieillissement de la peau
CN104491599A (zh) * 2014-12-11 2015-04-08 吴燕 一种治疗渗出性皮肤病的中药组合物
KR102534261B1 (ko) * 2023-02-27 2023-05-30 주식회사 바이오코스 몰로키아 추출물과 민들레 및 보리 복합 추출물을 포함하는 팽창선조 예방, 개선 또는 치료용 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120764A (en) * 1988-11-01 1992-06-09 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US6277622B1 (en) * 1997-08-11 2001-08-21 The University Of Sydney Synthetic polynucleotides
US6808707B2 (en) * 2000-02-04 2004-10-26 Matrix Design Wound healing compositions and methods using tropoelastin and lysyl oxidase
AU2001261194A1 (en) * 2000-05-03 2001-11-12 University Of Hawaii Novel members of the lysyl oxidases family of amine oxidases related applications
WO2001092322A1 (fr) * 2000-05-26 2001-12-06 Coletica Utilisation de collagene d'origine aquatique pour la realisation de supports destines a l'ingenierie tissulaire, et supports et biomateriaux obtenus
EP1289383B1 (fr) * 2000-05-30 2006-05-03 Societe Des Produits Nestle S.A. Composition primaire contenant un compose bioactif lipophile
WO2002061092A2 (fr) * 2001-01-29 2002-08-08 Bayer Aktiengesellschaft Regulation de la lysyl oxydase humaine

Also Published As

Publication number Publication date
KR20040107419A (ko) 2004-12-20
KR20070077515A (ko) 2007-07-26
KR100787553B1 (ko) 2007-12-21
KR100844914B1 (ko) 2008-07-09
DE102004028300A1 (de) 2005-03-24
DE102004028300B4 (de) 2005-11-24
US20040258676A1 (en) 2004-12-23
FR2855969A1 (fr) 2004-12-17

Similar Documents

Publication Publication Date Title
FR2890310B1 (fr) Utilisation des protoberberines comme agents regulant l'activite de l'unite pilosebacee
EP1898903A4 (fr) Inhibiteurs de l'activite akt
EP1718152A4 (fr) Modulateurs aminocyclopentyle pyridopyrazinone de l'activite des recepteurs de chimiokines
EP1850843A4 (fr) Inhibiteurs d'activite d'akt
EP2085392A4 (fr) Dérivé d'haloalkylsulfonanilide ou sel de celui-ci, herbicide comprenant le dérivé comme ingrédient actif, et utilisation de l'herbicide
EP1494676A4 (fr) Derives de quinolaxine fusionnee comme inhibiteurs de l'activite d'akt
EP1494675A4 (fr) Inhibiteurs de l'activite de akt
EP1931637A4 (fr) Methodes permettant de moduler l'activite induite par la neurotrophine
EP1679962A4 (fr) Seves moleculaires de zeolite pour l'elimination des toxines
EP1710308A4 (fr) Procede permettant de renforcer l'activite d'un anticorps
FR2927335B1 (fr) Hydrolysat de proteines de poissons presentant une activite satietogene, compositions nutraceutiques et pharmacologiques comprenant un tel hydrolysat et procede d'obtention
WO2005009387A3 (fr) Derives de l'azepine comme agents pharmaceutiques
CA2474511A1 (fr) Derives de benzofurane et de benzothiophene utilises dans le traitement de troubles hyperproliferatifs
BR0014990A (pt) Derivados de tetrahidrotiopirano ranftalazinona como inibidores de pde4
EP1716134A4 (fr) Composes amino heterocycliques modulateurs de l'activite des recepteurs de chimiokines
WO2002086078A3 (fr) Synthese et evaluation de nouvelles substances mimetiques de phthalimide comme agents antiangiogenese
EP1599206A4 (fr) Modulateurs d'heterotricylicamide fusionne avec un aminocyclopentyl de l'activite des recepteurs de la chimiokine
EP1844157A4 (fr) Stratégies pour élaborer des médicaments qui ciblent la famille d'enzymes sir2
EP1742915A4 (fr) Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulant l'activite des recepteurs de la chimiokine
SE0203353L (sv) Korrugerad produkt
FR2909180B1 (fr) Methode de mesure fonctionnelle de l'activite de la thrombomoduline plasmatique.
MXPA05012743A (es) Composicion de limpieza mejorada.
WO2006134486A3 (fr) Composes alpha-(aryl-ou heteroaryl-methyl)-beta piperidino propanamide utiles en tant qu'antagonistes du recepteur orl1
EP1717244A4 (fr) Polypeptide inhibant specifiquement l'activite d'akt
FR2850578B1 (fr) Utilisation de n-arylmethylene ethylenediaminetriacetates, n-arylmethyleneiminodiacetates ou n,n'-diarylmethylene ethylenediamineacetates comme donneurs de no

Legal Events

Date Code Title Description
CD Change of name or company name
PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20